Overview

A Single-center, Prospective,Randomized Study of Antiplatelet Effects of Ticagrelor Versus Clopidogrel in Patients With Dual Anti-platelet Therapy After Coronary Artery Bypass Grafting

Status:
Completed

Trial end date:
2016-10-01

Target enrollment:

Participant gender:

Summary

This study is designed to demonstrate that the onset of the antiplatelet effect of 90mg bid dose ticagrelor is more rapid and greater than 75 mg qd dose clopidogrel in patients undergoing CABG surgery.

Phase:

Phase 4

Details

Lead Sponsor:

Chinese Academy of Medical Sciences, Fuwai Hospital

Treatments:

Clopidogrel
Ticagrelor
Ticlopidine